Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Establishment of a PDT Patient Registry
- Conditions
- Lung Cancer
- First Posted Date
- 2018-07-17
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- Concordia Laboratories Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT03589456
- Locations
- 🇺🇸
John Muir Clinical Research Center, Concord, California, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸University of Florida, Gainesville, Florida, United States
Safety of PDT-Photofrin® Prior to Lung Surgery
- Conditions
- Lung CancerLung Cancer Metastatic
- Interventions
- Device: Fiber optic
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Concordia Laboratories Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03344861
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸University of Colorado, Denver, Colorado, United States
🇺🇸Moffitt Cancer Center, Tampa, Florida, United States
Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer
- Conditions
- Non-small Cell Lung Cancer (NSCLC)Lung Metastasis
- Interventions
- Device: Fiber optic
- First Posted Date
- 2016-09-27
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Concordia Laboratories Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT02916745
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸Southeastern Regional Medical Center, Atlanta, Georgia, United States
🇺🇸Alexian Brothers Hospital Network, Elk Grove Village, Illinois, United States
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
- Conditions
- Hilar Cholangiocarcinoma
- Interventions
- Drug: Photodynamic therapy-PhotofrinProcedure: Stenting procedureDrug: Chemotherapy regimen
- First Posted Date
- 2014-03-10
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Concordia Laboratories Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT02082522
- Locations
- 🇺🇸
Western Regional Medical Center, Inc., Goodyear, Arizona, United States
🇺🇸Mayo Clinic Cancer Center, Scottsdale, Arizona, United States
🇺🇸University of Southern California Keck School of Medicine, Los Angeles, California, United States